Cannabis Science Podcast – Détails, épisodes et analyse

In this episode we take a deep dive into some of the most fascinating aspects of cannabis that not even I had heard of before. We sit down with Dr. Alex Guenther and Dr. William Vizuete of Pacific Environmetal Analytics, to explore the increadible role plants play within our complex atmosphere. But most importantly, how within the entire plant kingdom Cannabis stands out as a particulalry unique and valuable species.

Ever wondered what would happen if you used cannabis before a run, lifting weights, or playing a sport? Does cannabis help or hinder performance? As an athlete myself, I have been very curious about these exact questions as well as many others. Today we’ll be taking a look at what the science has to says about cannabis use in sports and fitness. If you are an elite athlete or just a physically active person who enjoys cannabis, this episode is for you.
Additional information and references:
https://cannabisconciencia.org/
http://www.coopradio.org/

With all the focus on THC and CBD, we often forget that it all started with CBN. Discovered long before any of the other more famous cannabinoids, cannabinol (aka CBN), has had a long and fascinating history. Despite this, only recently has CBN garnered the spotlight as a valuable therapeutic alternative to THC. The team takes a really deep dive in one of our most researched episodes yet. Join us as we reveal the often-untold scientific story of cannabinol.
Additional information and references:
https://cannabisconciencia.org/
http://www.coopradio.org/

The Canadian Government in the last few years has been on the global vanguard of cannabis industry regulations. A critical job within this new Canadian cannabis industry is that of Quality Assurance Person (or QAP). This science focused position forms the foundation for the operations of all licensed producers and cannabis processing facilities, but what does it actually entail? Today we speak with Dr. Cris Alves, CSP member and long-time QAP for various companies. We discuss requirements to become QAP, what the job entails, and both the good and bad of the position in our current cannabis industry. Join us in the first episode of our ongoing series exploring Cannabis Science Jobs.
Additional information and references:
https://cannabisconciencia.org/
http://www.coopradio.org/

Back from a well-earned vacation, Dr. Cris Alves discusses the latest in cannabis science and industry news. Today he discusses an in-depth article from the United States Centers for Disease Control and Prevention on the causes behind vaping associated lung injuries in North America. We will continue to provide accurate updates on this very serious phenomenon as they become available.
Additional information and references:
https://cannabisconciencia.org/
http://www.coopradio.org/

I’m sure many people have heard about the “Entourage Effect”, also known as synergism between cannabinoids and other compound in cannabis. But is that actually true? Can the compounds in cannabis really come together to create a significantly different effect or is it just that these compounds are each beneficial and are able to coexist together. Each one having a specific beneficial effect that is simply present or not depending whether you have the compounds there or not. In essence, is the saying “the whole is greater than the sum of its parts” an old stoner folktale or scientific fact? In this listener requested episode we’ve decided to bring in to the studio Dr. Cris Alves to help us properly answer this fascinating question.
Additional information and references:
https://cannabisconciencia.org/
http://www.coopradio.org/

Dr. Cris Alves discusses the latest in cannabis science and industry news. Today he reviews a paper from Simon Fraser University in Vancouver, BC. The paper titled; Pathogens and Molds Affecting Production and Quality of Cannabis sativa L., was published in the journal FRONTIERS IN PLANT SCIENCE.
Punja Z, et al. Pathogens and Molds Affecting Production and Quality of Cannabis sativa L. FRONTIERS IN PLANT SCIENCE. 2019
Additional information and references:
https://cannabisconciencia.org/
http://www.coopradio.org/

Stephen “Steve” Goldner was a pharma wunderkind. At age 22 he and his mentor created the modern formulation for methadone used as standard treatment for opioid dependence worldwide. Since then, he and his team have gotten 100’s of drugs and medical devices approved for sale around the world. Yet, as a child of the 60’s Steve saw first-hand the lasting horrors of the the Vietnam War on many of his closest friends and school mates. Driven to act by their unending suffering, Steven wanted to find a way to help his buddy’s and many others like them. His research led him to focus on cannabis as a viable option for the debilitating PTSD and chronic pain affecting many of these aging veterans. With his extensive drug development background Steve founded Pure Green, a company dedicated to creating novel clinically tested pharmaceutical-grade cannabis-based medicines. Join Steve and myself as we discuss some of the ground-breaking work being performed at the intersections of the cannabis and pharmaceutical industries!
Steve is always searching for talented young scientists to join him in this mission. If this sounds like you, go to https://cannabisconciencia.org/ to learn more.

Dr. Cris Alves discusses the latest in cannabis science and industry news. Today he reviews a paper from the Institute of Plant Sciences in Bet Dagan, Israel which focuses on furthering our understanding of synergism found within cannabis. The paper titled; Terpenoids and phytocannabinoids co-produced in Cannabis Sativa strains show specific interaction for cell cytotoxic activity, was published in the journal MOLECULES.
Namdar D, et al. Terpenoids and phytocannabinoids co-produced in Cannabis Sativa strains show specific interaction for cell cytotoxic activity. MOLECULES. 2019
Additional information and references:
https://cannabisconciencia.org/
http://www.coopradio.org/